Lyle W. Ostrow

Lyle W. Ostrow, MD, PhD, is an Associate Professor in the Department of Neurology at Lewis Katz School of Medicine, Temple University. With clinical expertise in neurology and amyotrophic lateral sclerosis (ALS), he leads research at the intersection of neuroimmunology, transcriptomics, and biomarker development.

• Education: MD and PhD in Biophysics from The State University of New York, Buffalo
• Training: Fellowship in Neuromuscular Medicine and Residency in Neurology at Johns Hopkins University

His research focuses on:

• ALS pathogenesis mechanisms (TDP-43 aggregation, RNA splicing, mitochondrial variants)
• Neuroimmune compartment analysis via single-cell transcriptomics
• Development of remote monitoring tools for ALS progression (spirometry, speech analysis)
• Drug repurposing strategies using genomic data

Recent publications highlight:

• Multi-omics approaches to ALS subtyping
• Role of retrotransposons in neurodegeneration
• Clinical trials for immunomodulatory therapies
• Neurogenetic overlaps between ALS, FTD, and other neurodegenerative conditions

While clinical awards aren't explicitly listed, patient reviews consistently rate him at 4.9/5 across all categories. His work integrates:

• Transcriptomic profiling of ALS tissue samples
• Development of novel therapeutic approaches (protein assembly modulation)
• Implementation of telemedicine solutions for ALS management